Geode Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.4M | Buy |
|
|||||
|
2025
Q1 | $41.3M | Buy |
|
|||||
|
2024
Q4 | $59.8M | Sell |
|
|||||
|
2024
Q3 | $86.1M | Sell |
|
|||||
|
2024
Q2 | $69.3M | Buy |
|
|||||
|
2024
Q1 | $56.6M | Buy |
|
|||||
|
2023
Q4 | $57.1M | Buy |
|
|||||
|
2023
Q3 | $52.2M | Buy |
|
|||||
|
2023
Q2 | $68.4M | Buy |
|
|||||
|
2023
Q1 | $49.4M | Buy |
|
|||||
|
2022
Q4 | $57M | Buy |
|
|||||
|
2022
Q3 | $54.5M | Buy |
|
|||||
|
2022
Q2 | $50.2M | Buy |
|
|||||
|
2022
Q1 | $52.5M | Buy |
|
|||||
|
2021
Q4 | $72.6M | Buy |
|
|||||
|
2021
Q3 | $81.1M | Buy |
|
|||||
|
2021
Q2 | $119M | Buy |
|
|||||
|
2021
Q1 | $71.5M | Buy |
|
|||||
|
2020
Q4 | $96.7M | Buy |
|
|||||
|
2020
Q3 | $38.9M | Buy |
|
|||||
|
2020
Q2 | $26.1M | Buy |
|
|||||
|
2020
Q1 | $17.2M | Buy |
|
|||||
|
2019
Q4 | $15.1M | Buy |
|
|||||
|
2019
Q3 | $12.9M | Buy |
|
|||||
|
2019
Q2 | $17.1M | Buy |
|
|||||
|
2019
Q1 | $18M | Buy |
|
|||||
|
2018
Q4 | $14.7M | Buy |
|
|||||
|
2018
Q3 | $15.4M | Buy |
|
|||||
|
2018
Q2 | $3.14M | Buy |
|
|||||
|
2018
Q1 | $2.92M | Buy |
|